Delivery Order 75N93018D00007-75N93024F00002
- This is a firm-fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the Department of Health and Human Services, to Eurofins Panlabs, Inc., a foreign-owned, for-profit contract research organization. The contract has a total ceiling value of $659,400.00 and a period of performance through September 11, 2024. It was issued under the NIAID's "Nonclinical Services for Development of Interventional Agents"...
- This is a $541,498.00 firm fixed-price delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization. The contract provides nonclinical services in support of the development of interventional agents, and is issued under the Nonclinical Services for Development of Interventional Agents indefinite delivery,...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $464,720.00 firm fixed price delivery order contract to Eurofins Panlabs, Inc. for nonclinical services to support the development of interventional agents for infectious diseases. The contract is associated with a larger indefinite delivery/indefinite quantity (IDIQ) vehicle titled "Nonclinical Services for Development of Interventional Agents."...
- This is a $133,500.00 Firm Fixed Price delivery order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Eurofins Panlabs, Inc. The contract is for screening of rodent pharmacokinetics to support lead optimization work, which is part of the agency's mission to develop interventional agents. This delivery order falls under a larger Nonclinical Services for Development of...
- This task order was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Eurofins Panlabs, Inc. under a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract for Nonclinical Services for Development of Interventional Agents. The task order, valued at $102,981.15, is for "Lead Optimization Screening Assays for Safety Profiling" and has a total potential value of $137,856.75. Eurofins Panlabs, a foreign-owned for-profit...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded Task Order E06 "Custom Screening Assays for Metabolic Stability and Peptidase Selectivity" to Eurofins Panlabs, Inc. for $359,026.82 on a firm fixed price basis. This task order is part of the Nonclinical Services for Development of Interventional Agents indefinite delivery/indefinite quantity (IDIQ) contract. Eurofins Panlabs, Inc. is a contract...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a Delivery Order contract to Eurofins Panlabs, Inc. on August 14, 2018. The $506,922.00 Firm Fixed Price contract is for lead optimization screening assays to evaluate absorption, distribution, metabolism, excretion (ADME), safety, and pharmacokinetic (PK) properties. This Delivery Order falls under the parent Nonclinical Services for Development...
- The National Institute of Allergy and Infectious Diseases awarded a $6.17M firm fixed-price delivery order to Eurofins Discovery Services North America, LLC for preclinical models of infectious diseases. The delivery order, issued on December 9, 2021, is scheduled for completion by November 30, 2026, and will be performed at the contractor's facility in St. Peters, Missouri. This award falls under the "Nonclinical Services for Development of Interventional Agents" master IDIQ vehicle...
- This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Eurofins Panlabs, Inc. for lead optimization screening assays for absorption, distribution, metabolism, excretion (ADMET) and safety profiling. The $471,022.00 contract is for services performed at the contractor's facilities in Weldon Spring, Missouri and is associated with the Nonclinical Services for...
- This is a firm fixed price delivery order issued by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute on Drug Abuse, to Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization. The $224,328 task order is for receptor binding and predictive toxicology services under an existing indefinite delivery/indefinite quantity (IDIQ) contract, HHSN271201800024I. No set-aside was used. Eurofins Panlabs has a history of...
- 75N93018D00007Indefinite Delivery Contract
- 75N93018D00007-75N93024F00002Delivery Order
This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Eurofins Panlabs, Inc., a foreign-owned, for-profit contract research organization. The $1,212,720.00 firm-fixed-price contract is for nonclinical services to support the development of interventional agents for infectious diseases. It is a task order under a larger NIAID indefinite delivery vehicle (IDV) contract for nonclinical services for the development of interventional agents. The contract has no small business set-aside designation. Eurofins Panlabs provides specialized scientific services to federal agencies, including receptor binding studies, safety pharmacology, predictive toxicology, and in vitro screening. This contract supports NIAID's research initiatives in infectious disease interventions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Other Administrative Action | $0 | 3/13/25 | |
| P00001 | Other Administrative Action | $0 | 3/13/25 | |
| Not listed | Not listed | $445.8k | 9/19/24 |